Dashboard
Manage Tickers

AMPH


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

piper-sandler-reiterates-overweight-on-amphastar-pharma-maintains-71-price-target
Piper Sandler Reiterates Overweight on Amp...
06/27/2024 15:59:49

Piper Sandler analyst David Amsellem reiterates Amphastar Pharma (NASDAQ:AMPH) with a Overweight and maintains $71 price tar...

amphastar-pharmaceuticals-authorized-a-50m-increase-to-the-companys-share-buyback-program
Amphastar Pharmaceuticals Authorized A $50...
06/04/2024 10:19:45

needham-reiterates-hold-on-amphastar-pharma
Needham Reiterates Hold on Amphastar Pharma
05/22/2024 15:53:50

Needham analyst Serge Belanger reiterates Amphastar Pharma (NASDAQ:AMPH) with a Hold.

amphastar-bags-fda-approval-for-albuterol-sulfate-inhalation-aerosol
Amphastar Bags FDA Approval for Albuterol ...
05/22/2024 10:36:42

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) today announced that the U.S. Food and Drug Administration ("FDA") has gr...

needham-reiterates-hold-on-amphastar-pharma
Needham Reiterates Hold on Amphastar Pharma
05/09/2024 10:40:56

Needham analyst Serge Belanger reiterates Amphastar Pharma (NASDAQ:AMPH) with a Hold.

amphastar-pharma-q1-2024-adj-eps-104-beats-077-estimate-sales-171800m-miss-174713m-estimate
Amphastar Pharma Q1 2024 Adj EPS $1.04 Bea...
05/08/2024 21:11:19

Amphastar Pharma (NASDAQ:AMPH) reported quarterly earnings of $1.04 per share which beat the analyst consensus estimate of $0.7...

federal-trade-commission-targets-junk-patent-listings-for-diabetes-weight-loss-asthma-drugs-from-companies-like-novo-nordisk-astrazeneca
Federal Trade Commission Targets 'Junk Pat...
05/01/2024 20:11:33

The FTC intensifies efforts against pharmaceutical patent listings, disputing junk patents for diabetes, weight loss, asthma, a...

amphastar-pharmaceuticals-interested-in-potential-acquisitions-in-endocrinology-focused-companies
Amphastar Pharmaceuticals Interested In Po...
04/10/2024 19:23:59

Amphastar Pharmaceuticals discusses the future of Baqsimi at the Needham Healthcare Conference, highlighting its potential amid...

needham-reiterates-hold-on-amphastar-pharma
Needham Reiterates Hold on Amphastar Pharma
04/10/2024 11:24:09

Needham analyst Serge Belanger reiterates Amphastar Pharma (NASDAQ:AMPH) with a Hold.

jp-morgan-initiates-coverage-on-amphastar-pharma-with-overweight-rating-announces-price-target-of-60
JP Morgan Initiates Coverage On Amphastar ...
03/05/2024 11:21:37

JP Morgan analyst Ekaterina Knyazkova initiates coverage on Amphastar Pharma (NASDAQ:AMPH) with a Overweight rating and anno...

amphastar-pharma-q4-eps-088-misses-091-estimate-sales-17810m-beat-17567m-estimate
Amphastar Pharma Q4 EPS $0.88 Misses $0.91...
02/28/2024 21:25:14

Amphastar Pharma (NASDAQ:AMPH) reported quarterly earnings of $0.88 per share which missed the analyst consensus estimate of $0...

earnings-scheduled-for-february-28-2024
Earnings Scheduled For February 28, 2024
02/28/2024 11:24:02

Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenu...

earnings-outlook-for-amphastar-pharma
Earnings Outlook For Amphastar Pharma
02/27/2024 15:01:43

jim-cramer-says-hold-onto-this-biotech-stock-i-dont-understand-why-its-so-inexpensive
Jim Cramer Says Hold Onto This Biotech Sto...
01/17/2024 13:22:44

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he would back Moderna, Inc. (NASDAQ: MRNA) here.

b-of-a-securities-initiates-coverage-on-amphastar-pharma-with-neutral-rating-announces-price-target-of-63
B of A Securities Initiates Coverage On Am...
11/17/2023 13:12:57

B of A Securities analyst Jason Gerberry initiates coverage on Amphastar Pharma (NASDAQ:AMPH) with a Neutral rating and anno...

disney-twilio-transdigm-marathon-digital-and-other-big-stocks-moving-higher-on-thursday
Disney, Twilio, TransDigm, Marathon Digita...
11/09/2023 15:14:51

U.S. stocks traded mostly lower, with the Dow Jones falling around 75 points on Thursday. Here are some big stocks recording ga...

amphastar-pharma-q3-adj-eps-115-beats-069-estimate-sales-18056m-beat-17463m-estimate
Amphastar Pharma Q3 Adj EPS $1.15 Beats $0...
11/08/2023 21:45:58

Amphastar Pharma (NASDAQ:AMPH) reported quarterly Adj earnings of $1.15 per share which beat the analyst consensus estimate of ...

recap-amphastar-pharma-q3-earnings
Recap: Amphastar Pharma Q3 Earnings
11/08/2023 21:35:30

earnings-scheduled-for-november-8-2023
Earnings Scheduled For November 8, 2023
11/08/2023 09:21:00

Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its third quarter.

earnings-preview-for-amphastar-pharma
Earnings Preview For Amphastar Pharma
11/07/2023 14:01:47

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)
07/16/2024 Teladoc Health, Inc. (TDOC)
07/16/2024 Vestis Corporation (VSTS)
07/22/2024 Cambium Networks Corporation (CMBM)
07/22/2024 Biogen Inc. (BIIB)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)